Court Halts Boehringer’s COPD Inhaler Comparative Claims Vs. GSK Products

 
• By Brenda Sandburg
Inhaler
Court enjoins Boehringer Ingelheim from making false and misleading statements about GSK's dry powder inhalers

More from Marketing & Advertising

More from Compliance